Lorenz Kallenbach1, Marco K Vallazza2. Show Affiliations » 1. Merck KGaA, Aubonne, Switzerland. 2. Merck KGaA, Darmstadt, Germany.
Abstract
Mesh: See more » Biotechnology/legislation & jurisprudenceClinical Trials as Topic/legislation & jurisprudenceEuropeHumansPatents as Topic/legislation & jurisprudence
Year: 2018 PMID: 30307932 DOI: 10.1038/nbt.4265
Source DB: PubMed Journal: Nat Biotechnol ISSN: 1087-0156 Impact factor: 54.908